JPS6242916B2 - - Google Patents

Info

Publication number
JPS6242916B2
JPS6242916B2 JP56054471A JP5447181A JPS6242916B2 JP S6242916 B2 JPS6242916 B2 JP S6242916B2 JP 56054471 A JP56054471 A JP 56054471A JP 5447181 A JP5447181 A JP 5447181A JP S6242916 B2 JPS6242916 B2 JP S6242916B2
Authority
JP
Japan
Prior art keywords
formula
general formula
compound
solution
rifamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56054471A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56161392A (en
Inventor
Marushiri Reonarudo
Furancheshi Jobanni
Sanfuiritsuho Aurora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUARUMITARIA KARURO ERUBA SpA
Original Assignee
FUARUMITARIA KARURO ERUBA SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUARUMITARIA KARURO ERUBA SpA filed Critical FUARUMITARIA KARURO ERUBA SpA
Publication of JPS56161392A publication Critical patent/JPS56161392A/ja
Publication of JPS6242916B2 publication Critical patent/JPS6242916B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5447181A 1980-04-12 1981-04-13 3-amidinorifamycin, its derivative, manufacture of their novel compounds, antibacterial medicinal composition containing them Granted JPS56161392A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8012168 1980-04-12

Publications (2)

Publication Number Publication Date
JPS56161392A JPS56161392A (en) 1981-12-11
JPS6242916B2 true JPS6242916B2 (2) 1987-09-10

Family

ID=10512762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5447181A Granted JPS56161392A (en) 1980-04-12 1981-04-13 3-amidinorifamycin, its derivative, manufacture of their novel compounds, antibacterial medicinal composition containing them

Country Status (5)

Country Link
US (1) US4327096A (2)
JP (1) JPS56161392A (2)
BE (1) BE888310A (2)
DE (1) DE3106229A1 (2)
IT (1) IT1135270B (2)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447432A (en) * 1981-11-17 1984-05-08 Farmitalia Carlo Erba S.P.A. Azino rifamycins
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione
GB8308166D0 (en) * 1983-03-24 1983-05-05 Erba Farmitalia Preparation of azinomethyl-rifamycins
US4652644A (en) * 1985-04-29 1987-03-24 Bristol-Myers Company Process for preparation of N7 -amidino substituted mitomycin C derivatives
US4743619A (en) * 1985-08-29 1988-05-10 American Home Products Corporation Method of treating hepatitis
US4631290A (en) * 1985-08-29 1986-12-23 American Home Products Corporation Method of treating hepatitis
JPH02501926A (ja) * 1987-10-27 1990-06-28 チバ‐ガイギー　アクチェンゲゼルシャフト 置換されたアザシクロヘキシル誘導体
US5003070A (en) * 1988-06-30 1991-03-26 Ciba-Geigy Corporation Substituted azacyclohexyl derivatives of rifamycins
DE69400631T2 (de) * 1993-05-05 1997-02-27 Palo Alto Medical Foundation, Palo Alto, Calif. Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
DE10216719B4 (de) * 2002-04-10 2007-09-20 Helmholtz-Zentrum Für Umweltforschung Gmbh - Ufz N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose
US7247634B2 (en) * 2004-01-13 2007-07-24 Cumbre Pharmaceuticals Inc. Rifamycin derivatives effective against drug-resistant microbes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH512510A (de) * 1965-08-24 1971-09-15 Ciba Geigy Ag Verfahren zur Herstellung von in 3-Stellung durch eine unsubstituierte oder substituierte Aminogruppe substituierten Derivaten von Rifamycin-S und Rifamycin-SV
IT1068367B (it) * 1975-11-12 1985-03-21 Archifar Ind Chim Trentino 3 aldimino rifamicine ad alta attivita antibiotica loro derivati e procedimento per ottenerle

Also Published As

Publication number Publication date
DE3106229A1 (de) 1981-12-10
IT1135270B (it) 1986-08-20
BE888310A (fr) 1981-07-31
IT8119473A0 (it) 1981-02-03
JPS56161392A (en) 1981-12-11
US4327096A (en) 1982-04-27

Similar Documents

Publication Publication Date Title
JPS6242916B2 (2)
DE3026172C2 (2)
AT405283B (de) Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
US4219478A (en) Rifamycin compounds
JPS6123192B2 (2)
DE2433105C2 (2)
SU1487814A3 (ru) СПОСОБ ПОЛУЧЕНИЯ 7-АМИНО-З-[3(4-КАРБАМОИЛ-1-ПИРИДИНИО)-1-ПРОПЕН1-ИЛ]-3-ЦЕФЕМ-4-КАРБОКСИЛАТА ч.
DE3927444A1 (de) Verwendung von amid-komplexverbindungen
EP0137132A2 (en) Process for the manufacture of 7,16-dioxa-2-aza-10-0-cladinosyl-12-0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)-hexadeca-1(2)-ene-8-one and novel intermediate used in this process
US4277601A (en) Preparation of sodium cefuroxime
KR880001284B1 (ko) 아지노 리파마이신 화합물의 제조방법
IL98725A (en) 3-[(5-methyl-2-furanyl)methyl]-4-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate, its preparation and pharmacetical compositions containing them
DE3044970C2 (2)
JPS6155918B2 (2)
DD209835A5 (de) Verbessertes verfahren zur herstellung von penicillansaeureestern
CA1213278A (en) 3-azinomethyl rifamycins
JPS6254112B2 (2)
EP0138058B1 (en) Novel 1,4-thiazine derivative
DE60120398T2 (de) Imidazopyridin-8-one
DE2033361C3 (de) Acylpropandiol-(13)-phosphorsäurecholinester und Verfahren zu deren Herstellung
SU858565A3 (ru) Способ получени производных 1,3-пергидротиазина
CA1114817A (en) Method of preparing vindesine sulfate
JP2569358B2 (ja) 新規化合物
RU2098419C1 (ru) Антибиотик рифамицинового ряда, обладающий антимикробной и микобактериальной противотурберкулезной активностью
CH649087A5 (de) 6-alpha-brompenicillansaeureester, ihre sulfoxide und sulfone.